Delivery Order SPE2DB22D2206-SPE2DB24FHE33

Award Date 5/14/24
Potential Completion Date 5/15/24
Potential Value $7.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lyrica 50 mg capsules. The $1,626.00 contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with the Defense Logistics Agency with a potential value of $999,999,999.00 and a performance period through...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 90-count bottles of the 300 mg Lyrica capsule medication. The $1,446.17 delivery order, which has a completion date of February 2, 2024, is not designated as a set-aside contract. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, providing a wide range of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lyrica 50 mg capsules. The contract has a ceiling value of $10,532.81 and a performance period through April 10, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lyrica 100 mg capsules. The contract has a ceiling value of $1,647.67 and a period of performance through April 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,635,980 units of Lyrica 25 mg capsules. The order, valued at $2,873.95, has a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Additionally, Amerisourcebergen Drug Corp holds an...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $3,364.43 contract is for the delivery of Lyrica 50 mg capsules, with a performance period through February 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,510.07 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Lyrica 100 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563563934 LYRICA 50 MG CAPSULE UD 100S. The contract has a potential value of $2,068.56 and a completion date of February 7, 2024. This delivery order is being issued under an Indefinite Delivery Contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lyrica 75 mg capsules. The $12,389.87 order has a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lyrica 75 mg capsules in 90-count bottles. The contract, valued at $1,669.62, was awarded on June 17, 2024 by the Defense Logistics Agency (DLA), with a completion date of June 18, 2024. The contract is a firm-fixed price delivery order, without a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHE33
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 90-count bottles of the prescription drug Lyrica 50 mg capsules. The firm-fixed-price contract, valued at $7,441.75, has a period of performance ending on May 15, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to supply a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen, a major pharmaceutical distribution company, has a significant presence in the federal medical supply market, having also received a smaller IDC with the Department of Justice Federal Bureau of Investigation valued up to $750,000 through May 2024.

Generated 8/13/24, 11:21 AM